Ayşegül Aksu

Dr. Ayşegül Aksu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2019 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
EAEmine Acar
Emine Acar
ÖÖÖzhan Özdoğan
Özhan Özdoğan
AAAyşegül Aksu
Ayşegül Aksu
EDErkan Derebek
Erkan Derebek
RBRecep Bekiş
Recep Bekiş
GKGamze Çapa Kaya
Gamze Çapa Kaya

6 January 2022 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
AAAyşegül Aksu
Ayşegül Aksu
ÖTÖzge Vural Topuz
Özge Vural Topuz
GYGülşah Yılmaz
Gülşah Yılmaz
GKGamze Çapa Kaya
Gamze Çapa Kaya
BYBurçak Yılmaz
Burçak Yılmaz

5 February 2021 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
AAAyşegül Aksu
Ayşegül Aksu
NŞNazli Pinar Karahan Şen
Nazli Pinar Karahan Şen
ETEmine Burçin Tuna
Emine Burçin Tuna
GAGüven Aslan
Güven Aslan
GKGamze Çapa Kaya
Gamze Çapa Kaya
Background: The aim of this study was to investigate the relationship between volumetric data obtained from staging 68Ga-prostate-specific membrane antigen (PSMA) PET computerized tomography (CT) images with prostate-specific antigen (PSA), risk groups, Gleason Grade (GG) groups and presence of metastasis. Methods: We performed a retrospective analysis of 68Ga-PSMA PET-CT images from 88 patients undergoing initial staging of prostate adenocarcinoma between January 2015 and September 2018. Images were evaluated in LIFEx software; PSMA involvement above the background activity in prostate gland, lymph node and other distant metastases was plotted with 40% SUVmax threshold, SUVmax, PSMA tumor volume (PSMA-TV) and total lesion PSMA (TL-PSMA) values were obtained. Results: In all patients, there was a moderate correlation between PSA and PSMA-tumor volume whole-body (PSMA-TVwb) (P < 0.001, r = 0.580) and a high correlation between total lesion-PSMAwb (TL-PSMAwb) (P < 0.001, r = 0.636). Prostate PSMA-TV (PSMA-TVp) and TL-PSMA (PSMA-TVp) values were different in local and locally advanced/metastatic patients (P = 0.020 and 0.006, respectively). PSMA-TVp and TL-PSMAp values were significantly different in low-moderate and high-risk patients (P = 0.003 and <0.001, respectively), and in patients with and without metastasis (P = 0.008 and 3 (P = 0.030, 0.002, <0.001 and <0.001, respectively). Conclusion: Pretreatment 68Ga-PSMA PET/CT volumetric parameters provides unique data to use in the clinical decision-making process of patients with adenocarcinoma of the prostate.

28 July 2020 in Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
AAAyşegül Aksu
Ayşegül Aksu
NŞNazlı Pınar Karahan Şen
Nazlı Pınar Karahan Şen
EAEmine Acar
Emine Acar
GKGamze Çapa Kaya
Gamze Çapa Kaya

2 February 2022 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ÖTÖzge Vural Topuz
Özge Vural Topuz
AAAyşegül Aksu
Ayşegül Aksu
SESadife Rüya Erinç
Sadife Rüya Erinç
NTNedim Tokgözoğlu
Nedim Tokgözoğlu
MTMuge Oner Tamam
Muge Oner Tamam
Endometrial cancer (EC) is the most common gynecological malignancy. The 18fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) is used for initial staging, evaluating treatment response, and detecting recurrence. This study aimed to investigate the diagnostic value of preoperative PET/CT in EC staging and determine the volumetric PET parameters that are accurate predictors of histopathological tumor characteristics. Preoperative PET/CT data of 66 patients with EC were retrospectively analyzed. Patients were divided into low and high-risk groups according to the European Society for Medical Oncology criteria. The maximum standardized uptake value (SUVmax), SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary lesion and pathological lymph nodes were noted. The International Federation of Gynecology and Obstetrics (FIGO) classifications, histopathology, the depth of myometrial invasion (MI), lymph node metastasis (LNM), cervical stromal invasion (CSI), and tumor sizes were noted. The SUVmax, TLG, and MTV values of high and low-risk groups were significantly different. TLG was the most useful parameter in differentiating risk groups. PET/CT had 90% sensitivity, 96.3% specificity, 81.8% positive predictive value, 98.1% negative predictive value, and 95.45% accuracy in assessing LNM. MTV and TLG values in patients with non-endometrioid pathology were higher than those with endometrioid. The SUVmax, MTV, and TLG of patients with deep MI were higher than those with superficial MI. TLG values of patients with CSI were higher than those without CSI. Patients with LNM had higher MTV and TLG values than those without LNM. A significant difference was found in TLG, MTV, and SUVmax values between patients with FIGO stage I-II and patients with FIGO stage III and above. SUV and volumetric parameters obtained from PET/CT, especially TLG, are strong predictors of tumor characteristics, such as MI and CSI, FIGO stages, and LNM, and are useful in noninvasively defining the risk groups in the preoperative period.

30 March 2022 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
AAAyşegül Aksu
Ayşegül Aksu
CŞCihan Şin
Cihan Şin
BYBurçak Yilmaz
Burçak Yilmaz
The scan demonstrated multiple linear and patchy hypermetabolic lesions in skeletal muscles, mimicking the coat of a tiger, and was referred to as “a tiger man” sign. A 38-year-old man was admitted to our hospital with weakness, shortness of breath, and muscle pain. A CT scan showed a mass in the anterior mediastinum. 18F-FDG PET/CT was performed to evaluate the mass with a preliminary diagnosis of thymoma; heterogeneous 18F-FDG uptake in the mediastinal mass and tiger man findings in skeletal muscles were observed in PET/CT images.